Human Gene Therapy is pleased to provide a full range of robust Author Services. Click links below for program details.
Manuscript Submission Guidelines |
|
Human Gene Therapy (HGT), celebrating its 25th anniversary, has published over 4,000 papers, reviews, and editorials. Over the last 2 years we expanded the Human Gene Therapy portfolio to include Human Gene Therapy Methods and Human Gene Therapy Clinical Development. Submit your research today and join the growing HGT community! •Manuscript Submission Guidelines for Human Gene Therapy |
|
Guidelines for Writing a Research PaperAs a resource for new and first-time submitters, we provide general guidelines for writing a quality research paper, translated into 10 languages. Authors referring to these basic recommendations should also consult the specific manuscript instructions for the Journal to which they will be contributing for detailed submission information. |
|
White Paper:
|
Author Benefit Programs |
|
*AuthorCite®AuthorCite® is a dynamic author services platform that delivers a 360-degree view of your article from submission to publication to market impact, with comprehensive tools to take control of how your work is read, shared, and measured. |
|
*Exclusively licensed by Mary Ann Liebert Inc., publishers | |
Liebert Open Access OptionThe Liebert Open Access Option program provides immediate free online posting of your article upon publication without an embargo period, for a flat one-time fee. This fee also makes the article free in perpetuity on the Liebertpub.com site. If you've received NIH funding we will also immediately deposit your paper to PubMed Central (PMC). |
Our Policies |
NIH Public Access PolicyIn order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after publication. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc. |
HHMI and Wellcome TrustAuthors Funded by HHMI and Wellcome Trust should follow the instructions for Liebert Open Option above. Contact AuthorServices@liebertpub.com for specific questions regarding our HHMI and Wellcome Trust policies. |
Self-ArchivingMary Ann Liebert, Inc. is a "blue" publisher, as we allow self-archiving of post-print (i.e. final draft post-refereeing) or publisher's version/PDF. |